HUP9702149A2 - Tachykinin receptor antagonista heterociklikus piperazinonszármazékok, intermedierjeik, előállításuk és alkalmazásuk, valamint a vegyületeket tartalmazó gyógyászati készítmények - Google Patents

Tachykinin receptor antagonista heterociklikus piperazinonszármazékok, intermedierjeik, előállításuk és alkalmazásuk, valamint a vegyületeket tartalmazó gyógyászati készítmények

Info

Publication number
HUP9702149A2
HUP9702149A2 HU9702149A HUP9702149A HUP9702149A2 HU P9702149 A2 HUP9702149 A2 HU P9702149A2 HU 9702149 A HU9702149 A HU 9702149A HU P9702149 A HUP9702149 A HU P9702149A HU P9702149 A2 HUP9702149 A2 HU P9702149A2
Authority
HU
Hungary
Prior art keywords
intermediates
compounds
pipe powder
preparation
tachykinin receptor
Prior art date
Application number
HU9702149A
Other languages
English (en)
Inventor
Timothy P. Burkholder
Elizabeth M. Kudlacz
Tieu-Binh Le
Original Assignee
Hoechst Marion Roussel, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Inc. filed Critical Hoechst Marion Roussel, Inc.
Publication of HUP9702149A2 publication Critical patent/HUP9702149A2/hu
Publication of HUP9702149A3 publication Critical patent/HUP9702149A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Tachykinin receptőr antagőnista heterőciklikűs piperazinőn-származékők, intermedierjeik, előállításűk és alkalmazásűk, valamint avegyületeket tartalmazó gyógyászati készítmények. A találmány szerintiindőlil-metil-piperazinőn-származékők (1) és intermedierjeik (2)általánős képletében G1-CH2-csőpőrt vagy -C(O)-csőpőrt; Ar1 adőttesetben szűbsztitűált fenil- vagy naftilcsőpőrt; R1 hidrőgénatőm, (c)képletű csőpőrt vagy -(CH2)qAr2 vagy -CH2C(O)Ar2 képletű csőpőrt, ahőlq = 1-4 közötti szám és Ar2 adőtt esetben szűbsztitűált fenil- vagyindőlilcsőpőrt; R2 hidrőgénatőm, alkil- vagy -CHO csőpőrt; R3hidrőgénatőm vagy adőtt esetben szűbsztitűált fenil- vagynaftilcsőpőrt; R5 hidrőgénatőm, alkil- vagy benzilcsőpőrt, és R6hidrőgénatőm, alkőxi-karbőnil- vagy benzil-őxi-karbőnil-csőpőrt. ŕ
HU9702149A 1995-03-15 1996-02-06 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds HUP9702149A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40478895A 1995-03-15 1995-03-15

Publications (2)

Publication Number Publication Date
HUP9702149A2 true HUP9702149A2 (hu) 1999-06-28
HUP9702149A3 HUP9702149A3 (en) 1999-07-28

Family

ID=23601038

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9702149A HUP9702149A3 (en) 1995-03-15 1996-02-06 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds

Country Status (21)

Country Link
US (2) US5840726A (hu)
EP (1) EP0815105B1 (hu)
JP (1) JP3825472B2 (hu)
KR (1) KR19980703032A (hu)
CN (1) CN1067068C (hu)
AR (1) AR002715A1 (hu)
AT (1) ATE206421T1 (hu)
AU (1) AU697599B2 (hu)
CA (1) CA2215333C (hu)
DE (1) DE69615670T2 (hu)
DK (1) DK0815105T3 (hu)
ES (1) ES2164235T3 (hu)
FI (1) FI973671A0 (hu)
HU (1) HUP9702149A3 (hu)
IL (1) IL117453A (hu)
NO (1) NO314693B1 (hu)
NZ (1) NZ302948A (hu)
PT (1) PT815105E (hu)
TW (1) TW464647B (hu)
WO (1) WO1996028441A1 (hu)
ZA (1) ZA961954B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000502100A (ja) * 1995-12-18 2000-02-22 藤沢薬品工業株式会社 タキキニン拮抗薬としてのピペラジン誘導体
DE19939910A1 (de) * 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
WO2005034857A2 (en) * 2003-09-05 2005-04-21 Sequella, Inc. Methods and compositions comprising diamines as new anti-tubercular therapeutics
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132882A1 (de) * 1981-08-20 1983-03-03 Cassella Ag, 6000 Frankfurt Neue piperazinone, ihre herstellung und verwendung
IE903957A1 (en) * 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1994003483A1 (en) * 1992-07-30 1994-02-17 Chiron Corporation Endothelin receptor-binding compounds
GB9222486D0 (en) * 1992-10-26 1992-12-09 Merck Sharp & Dohme Therapeutic agents
CN1081635C (zh) * 1993-05-06 2002-03-27 默里尔药物公司 取代的吡咯烷 －3－基－烷基－哌啶
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
KR19980703032A (ko) 1998-09-05
US5840726A (en) 1998-11-24
EP0815105B1 (en) 2001-10-04
HUP9702149A3 (en) 1999-07-28
ES2164235T3 (es) 2002-02-16
CA2215333C (en) 2002-01-01
TW464647B (en) 2001-11-21
PT815105E (pt) 2002-03-28
FI973671A (fi) 1997-09-12
NZ302948A (en) 2001-05-25
ZA961954B (en) 1996-09-17
DE69615670T2 (de) 2002-08-08
IL117453A (en) 2000-07-26
WO1996028441A1 (en) 1996-09-19
JPH11501917A (ja) 1999-02-16
DK0815105T3 (da) 2002-01-21
NO974205L (no) 1997-11-13
DE69615670D1 (de) 2001-11-08
JP3825472B2 (ja) 2006-09-27
AU697599B2 (en) 1998-10-08
CN1067068C (zh) 2001-06-13
FI973671A0 (fi) 1997-09-12
NO974205D0 (no) 1997-09-12
CA2215333A1 (en) 1996-09-19
IL117453A0 (en) 1996-07-23
EP0815105A1 (en) 1998-01-07
ATE206421T1 (de) 2001-10-15
CN1178529A (zh) 1998-04-08
MX9706872A (es) 1997-11-29
US5864045A (en) 1999-01-26
AU4930696A (en) 1996-10-02
NO314693B1 (no) 2003-05-05
AR002715A1 (es) 1998-04-29

Similar Documents

Publication Publication Date Title
FI941987A (fi) Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset
TR199801594A2 (xx) CCR-3 resept�r antagonistleri.
MX9803407A (es) Derivados de piperazina 1-(1,2-disustituido piperidinil)-4-sustituidos.
HUP0303339A2 (hu) Heteroaril-karbamid neuropeptid Y Y5 receptor antagonisták, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HUP9802694A1 (hu) Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
MY117557A (en) 1-(1,2-disubstituted piperidinyl)-4- substituted piperidine derivatives
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
HUP9901209A2 (hu) Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
HUP0303398A2 (hu) 1,2-Dihidropiridin-származékok, eljárás előállításukra és alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
WO2002098856A3 (en) Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
IL102703A (en) N-sulfonyl indoline derivatives carrying an amide functional group, their preparation and pharmaceutical compositions containing them
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
NO974734D0 (no) Arylglycinamidderivater, fremgangsmåte for fremstilling av disse forbindelsene og farmasöytiske blandinger inneholdende slike forbindelser
HUP9903948A2 (hu) Tachikinin antagonista 1-(1,2-diszubsztituált piperidinil)-4-(kondenzált imidazolil)-piperidin-származékok, előállításuk és alkalmazásuk
YU8197A (sh) Novi derivati arilglicinamida, postupci za njihovo pripremanje i farmaceutski preparati koji sadreže ova jedinjenja
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
TR199801218T2 (xx) Takikinin antagonistleri olarak N-asil-2-ikameli-4-(Benzimidazolil-ya da imidazopiridinil-ikameli art�klar)-piperidinler.
MX9706394A (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina, especialmente neuroquinina-1.
HUP9801950A2 (hu) 2-(Aril-fenil-amino)-imidazolin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP9702149A2 (hu) Tachykinin receptor antagonista heterociklikus piperazinonszármazékok, intermedierjeik, előállításuk és alkalmazásuk, valamint a vegyületeket tartalmazó gyógyászati készítmények
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
HUP0203622A2 (hu) Biciklusos vazopresszin agonisták és ezeket tartalmazó gyógyszerkészítmények
HUP0303513A2 (hu) Szubsztituált pirazinkinoxalin-származékok mint szerotonin receptor agonisták és antagonisták, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HUP0102522A2 (hu) 3',3'-N-bisz-helyettesített makrolid LHRH antagonista vegyületek és alkalmazásuk, eljárás előállításukra, valamint e vegyületeket tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees